Skip to main content

Table 2 Baseline demographics

From: Efficacy and safety of ferric carboxymaltose versus ferrous sulfate for iron deficiency anemia during pregnancy: subgroup analysis of Korean women

 

Korean subgroup

Non-Korean subgroup

FCM (n = 45)

FS (n = 44)

FCM (n = 78)

FS (n = 80)

Age, years

34.5 ± 4.8

33.4 ± 4.9

29.6 ± 5.6

29.5 ± 5.2

Pre-pregnancy weight, kg

53.9 ± 8.0

54.7 ± 8.7

62.4 ± 12.2

58.9 ± 11.4

Pre-pregnancy BMI, kg/m2

23.7 ± 2.7

25.0 ± 3.3

25.6 ± 4.3

24.6 ± 3.9

Baseline weight, kg

61.3 ± 7.7

63.8 ± 9.5

70.1 ± 13.5

66.5 ± 12.0

Baseline weight category, n (%)

  < 66 kg

35 (77.8)

28 (63.6)

34 (43.6)*

40 (50.0)

  ≥ 66 kg

10 (22.2)

16 (36.4)

44 (56.4)

40 (50.0)

 Overall total dose, mg

1066 ± 172

12,286 ± 3596

1006 ± 170

11,777 ± 5124

 Baseline Hb level, g/dL

9.68 ± 0.92

9.84 ± 1.55

9.82 ± 0.79

9.98 ± 0.89

Baseline Hb level category, n (%)

  ≤ 9.0 g/dL

11 (24.4)

6 (13.6)

11 (14.1)

11 (13.8)

  > 9.0 g/dL

34 (75.6)

38 (86.4)

67 (85.9)

68 (85.0)

Baseline serum ferritin

  ≤ 10 ng/mL

36 (80.0)

28 (63.6)

62 (79.5)

58 (72.5)

  > 10 ng/mL

9 (20.0)

15 (34.1)

14 (17.9)

22 (27.5)

Gestational age category

 16 to < 20 weeks

3 (6.7)

2 (4.5)

9 (11.5)

7 (8.8)

 20 to < 33 weeks

40 (88.9)

40 (90.9)

65 (83.3)

70 (87.5)

  ≥ 33 weeks

2 (4.4)

2 (4.5)

4 (5.1)

3 (3.8)

  1. Results presented here are mean (and standard deviation) unless otherwise stated
  2. BMI body mass index, FCM Ferric carboxymaltose, FS ferrous sulfate
  3. *P < 0.05 vs. Korean subgroup FCM. Values with no asterisk have no statistically significant difference when compared with other three values in the same row using Student’s t-test, chi-square test, or Fisher’s exact test